Skip to main content
Elsevier

Journals in Oncology

Focusing on tumor biology, diagnostics, and targeted therapies, this portfolio supports oncologists, researchers, and clinicians. It features innovations that improve cancer detection, personalized treatments, and survivorship care.

  • International Journal of Gynecological Cancer

    • ISSN: 1048-891X
    The International Journal of Gynecological Cancer (IJGC) serves as the primary educational and informational publication on topics related to the detection, prevention, diagnosis, and treatment of gynecologic malignancies.The content is intended for gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology.IJGC promotes a multidisciplinary approach and features original research, reviews, and video articles.IJGC is the official journal of the European Society of Gynaecological Oncology (ESGO) and the International Gynecologic Cancer Society (IGCS).
    Subscriptions

  • HPB

    • ISSN: 1365-182X
    To visit the HPB journal website click here: http://www.hpbonline... is an international forum for clinical, scientific and educational communication.Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.HPB is owned by the International Hepato-Pancreato-Bil... Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Bil... Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).
    Subscriptions

  • Cancer Genetics

    • ISSN: 2210-7762
    The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.Cancer Genetics is proud to be affiliated with the Cancer Genomics Consortium.
    Subscriptions

  • Auris Nasus Larynx

    • ISSN: 0385-8146
    The Official Journal of the Japanese Society of Otorhinolaryngology-... and Neck Surgery. The international journal Auris Nasus Larynx provides the opportunity for rapid, carefully reviewed publications concerning the fundamental and clinical aspects of otorhinolaryngology and related fields. This includes otology, neurotology, bronchoesophagology, laryngology, rhinology, allergology, head and neck medicine and oncologic surgery, maxillofacial and plastic surgery, audiology, speech science.Original papers, short communications and original case reports can be submitted. Reviews on recent developments are invited regularly and Letters to the Editor commenting on papers or any aspect of Auris Nasus Larynx are welcomed.Founded in 1974 and previously published by the Society for Promotion of International Otorhinolaryngology, the journal is now the official English-language journal of the Japanese Society of Otorhinolaryngology-... and Neck Surgery. The aim of its new international Editorial Board is to make Auris Nasus Larynx an international forum for high quality research and clinical sciences.
    Subscriptions

  • Human Pathology

    • ISSN: 0046-8177
    Human Pathology is designed to bring information of clinicopathologic significance to human disease to the laboratory and clinical physician. It presents information drawn from morphologic and clinical laboratory studies with direct relevance to the understanding of human diseases. Papers published concern morphologic and clinicopathologic observations, reviews of diseases, analyses of problems in pathology, significant collections of case material and advances in concepts or techniques of value in the analysis and diagnosis of disease. Theoretical and experimental pathology and molecular biology pertinent to human disease are included. This critical journal is well illustrated with exceptional reproductions of photomicrographs and microscopic anatomy.Case reports should be submitted to our open access companion title, Human Pathology: Case Reports.
    Subscriptions

  • Drug Resistance Updates

    • ISSN: 1368-7646
    Drug Resistance Updates publishes inspiring original research, commentary and expert reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine. The Editors welcome and encourage the submission of original research articles while review articles are written by leaders in the field of drug resistance by invitation.
    Subscriptions

  • The American Journal of Pathology

    • ISSN: 0002-9440
    The American Journal of Pathology (AJP), the official journal of the American Society for Investigative Pathology (ASIP), seeks high-quality original research reports, reviews, and commentaries related to the molecular and cellular basis of disease. The editors will consider basic, translational, and clinical investigations that directly address mechanisms of pathogenesis or provide a foundation for future mechanistic inquiries. Examples of such foundational investigations include data mining, identification of biomarkers, molecular pathology, and discovery research. Foundational studies that incorporate deep learning and artificial intelligence are also welcome. High priority is given to studies of human disease and relevant experimental models using molecular, cellular, and organismal approaches. Case reports typically do not meet the criteria for inclusion.
    Subscriptions

  • The Journal of Nutritional Biochemistry

    • ISSN: 0955-2863
    Devoted to advancements in nutritional sciences, The Journal of Nutritional Biochemistry presents experimental nutrition and clinical nutrition research as it interfaces with biochemistry, molecular biology, physiology, and toxicology. The scope of the journal includes the broad area of in vivo and in vitro studies of mechanistic aspects of nutritional sciences. Preferred manuscripts include studies, which focus on nutrients and/or bioactive compounds with nutritional value derived from diets/whole foods as it relates to: biochemistry, molecular biology, toxicology, immunology or physiology and human health and diseases.Rigorous reviews by an international editorial board of distinguished scientists ensure publication of the most current and key research being conducted in nutrition at the cellular, animal and human level. In addition to its monthly features of critical reviews and research articles, The Journal of Nutritional Biochemistry also periodically publishes emerging issues, experimental methods, and other types of articles such as but not limited to policy statements.Contact InformationReto Asmis, Ph.D, Editor-in-Chief The Journal of Nutritional Biochemistry Professor, Internal Medicine, Section on Molecular Medicine Wake Forest School of Medicine Medical Center Boulevard, Winston-Salem, NC 27157 E-mail address: [email protected]...
    Subscriptions

  • Nutrition

    • ISSN: 0899-9007
    The International Journal of Applied and Basic Nutritional SciencesFounded by Michael M. Meguid in the early 1980's, Nutrition presents advances in nutrition research and science, informs its readers on new and advancing technologies and data in clinical nutrition practice, encourages the application of outcomes research and meta-analyses to problems in patient-related nutrition; and seeks to help clarify and set the research, policy and practice agenda for nutrition science to enhance human well-being in the years ahead. Papers on nutrition-related plant or animal sciences are unlikely to be considered as they are outside the main focus of the Journal.
    Subscriptions

  • American Journal of Preventive Medicine

    • ISSN: 0749-3797
    The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health.Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.
    Subscriptions

  • Nutrition Research

    • ISSN: 0271-5317
    An International Publication for Nutrition to Advance Food and Life Science ResearchThe mission of Nutrition Research is to serve as the premier journal for the global communication of nutrition sciences research. Our primary goal is to publish research across the broad field of nutrition sciences that advances human health and promotes clinical applications through a comprehensive understanding of dietary patterns, foods, nutrients, and bioactive food components. This understanding includes exploring diet-related interactions with environmental exposures, human behavior, genetics, and underlying health status.Nutrition Research aims to contribute to the advancement of fundamental knowledge and facilitate research translation in support of public health. We achieve this by publishing nutrition sciences research that establishes mechanisms and demonstrates the efficacy or detriment of dietary exposures and interventions. We welcome studies conducted in humans, populations, and cellular and animal models, particularly those related to biomolecular nutrition, precision nutrition, (multi)omic workflows, nutrition interventions, randomized controlled trials, and novel methodological approaches and techniques that advance the nutrition sciences field. Furthermore, Nutrition Research is committed to promoting diversity, equity, inclusivity, and justice in the field through the dedicated efforts of its globally diverse editorial board. We also actively encourage the submission of research from all geographic regions and topics addressing health inequities and improvements in the health of vulnerable and/or underrepresented populations.Nutritio... Research publishes peer-reviewed research and articles related to all aspects of nutrition sciences that are relevant to the health of humans and populations. We welcome the following types of submissions:Original ResearchNarrative reviewsSystematic Reviews/Meta-Analyse... Trial Protocols in Human NutritionMethodologi... Advances in Nutrition ResearchShort CommunicationsEditor... and OpinionsDavid Kritchevsky Graduate Student AwardSince 2010 Nutrition Research has sponsored the David Kritchevsky Graduate Student Award with support provided by Elsevier. This prestigious award recognizes outstanding articles published in Nutrition Research by graduate and professional students. Annually, two awards of $1000 (USD) each are presented to these early-career scientists.
    Subscriptions

  • Urologic Oncology: Seminars and Original Investigations

    • ISSN: 1078-1439
    Official Journal of the Society of Urologic OncologyUrologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.
    Subscriptions

  • European Journal of Oncology Nursing

    • ISSN: 1462-3889
    The European Journal of Oncology Nursing is an international journal which publishes research of direct relevance to patient care, nurse education, management and policy development. EJON is proud to be the official journal of the European Oncology Nursing Society.The journal publishes the following types of papers: • Original research articles • Review articles
    Subscriptions

  • European Urology Oncology

    • ISSN: 2588-9311
    Official Journal of the European Association of Urology European Urology Oncology is a companion title to European Urology , European Urology Open Science and European Urology Focus , and is the first official publication of the EAU fully devoted to the study of genitourinary malignancies.The journal aims to deliver high quality research while implementing a multi-disciplinary approach to incorporate Urology, Medical Oncology, Radiation Therapy, Imaging, Pathology and Basic Research with the ultimate goal of advancing research in urological oncology.European Urology Oncology includes original articles, opinion piece editorials and invited reviews covering clinical, basic and translational research and is published six times a year in electronic format. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.
    Subscriptions

  • Seminars in Oncology Nursing

    • ISSN: 0749-2081
    Seminars in Oncology Nursing (SON) is a unique, international peer-reviewed journal, published six times a year. It features special issues that offer a multi-faceted overview of a contemporary cancer topic, relevant to patient care, nursing education, management, and/or policy development. Each special issue is led by Guest Editors who solicit articles from invited expert authors. In addition to solicited articles, the Editor-in-Chief welcomes the submission of unsolicited original research and review articles. SON publishes on all aspects of cancer nursing, whether in the field of research, practice, or education.
    Subscriptions

  • Gynecologic Oncology

    • ISSN: 0090-8258
    Gynecologic Oncology is the The Society of Gynecologic Oncology's (SGO) official peer-reviewed journal. It is dedicated to publishing high-quality science and educational content that addresses the full continuum of gynecologic cancer care.The Journal will publish innovative research that provides actionable insights related to prevention, detection, treatment and survivorship in gynecologic cancers. The focus of these publications will generally be clinically relevant and includes clinical trials, radiation and surgical innovation, health outcomes and diversity research, epidemiology, and patient-centered quality of life research. Translational research with promise to affect clinical treatment innovation will receive priority.With an international editorial board of experts and key opinion leaders, the Journal will support multiple stakeholders as they aim to solve complex gynecologic cancer problems. Providing essential reading for all stakeholders we will publish original research, invited reviews, editorials, perspectives, and correspondence. Importantly, as the official journal of the SGO, the Journal will publish communications from the SGO including abstracts, practice statements and guidelines.
    Subscriptions

  • International Journal of Radiation Oncology, Biology, Physics

    • ISSN: 0360-3016
    An official journal of the American Society for Radiation OncologyInternationa... Journal of Radiation Oncology - Biology - Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.The Red Journal's related publications are Practical Radiation Oncology and Advances in Radiation Oncology. Learn more about which types of papers these journals typically accept.Disclaimer No responsibility is assumed by the Publisher or the American Society for Radiation Oncology for any injury and/or damage to persons or property as a result of any actual or alleged libelous statements, infringement of intellectual property or privacy rights, products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.The views expressed in The Red Journal (the "Journal") are those of the individual authors and are not necessarily those of the American Society for Radiation Oncology (ASTRO) or the Publisher. The information contained in the Journal is not medical advice and is not intended to replace the judgment of a practitioner with respect to particular patients, procedures, or practice. No responsibility is assumed by the Publisher nor by the Society for any injury and/or damage to persons or property as a result of (i) any actual or alleged libelous statements or infringement of intellectual property or privacy rights, (ii) product liability or negligence; (iii) an author's statements or other materials; or (iv) the use or operation of any ideas, instructions, procedures, products, or methods contained in the Journal. Due to rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should always be made. In any jurisdiction that does not permit such a disclaimer of liability, the liability of ASTRO and the Publisher shall be limited to the greatest extent allowed by applicable law.Publication of an advertisement in the Journal does not constitute on the part of the Publisher or the Society a guarantee or endorsement of the quality or value of the advertised products or services described therein or of any of the representations or the claims made by the advertisers with respect to such products or services.
    Subscriptions

  • Journal of Thoracic Oncology

    • ISSN: 1556-0864
    Official Journal of the International Association for the Study of Lung CancerAbout the JournalJournal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology. The journal is interested in receiving manuscripts dealing with epidemiology, prevention, screening, early detection, staging, cure, and treatment of thoracic malignancies. Submissions on tobacco control and cessation are of interest, particularly where there is direct relevance to lung cancer epidemiology and therapeutic outcomes. The Journal also welcomes submissions on pathologic and histologic classification and novel imaging and bronchoscopic approaches. Submissions regarding novel systemic therapies, particularly in the fields of biomarker targets, genomics, immunology, and cellular therapies are of interest. Novel radiotherapy and surgical techniques are of interest. Submission of randomized phase II and phase III trials, as well as meta analyses of individual participant data, are encouraged. Basic science studies must have direct clinical and translational relevance.Authors are also welcome to submit to the journal's open access companion title, JTO Clinical and Research Reports, which welcomes a range of manuscripts from subset analyses of published trials to high-quality case reports.
    Subscriptions

  • Journal of Pain and Symptom Management

    • ISSN: 0885-3924
    Advancing Palliative Care, Hospice, and Symptom ResearchOfficial Journal of the American Academy of Hospice and Palliative Medicine and the National Alliance for Care at Home The Journal of Pain and Symptom Management is an internationally respected, peer-reviewed journal and serves an interdisciplinary audience of professionals by providing a forum for the publication of the latest clinical research and best practices related to the relief of illness burden among patients afflicted with serious or life-threatening illness.The Journal has strongly supported both quantitative and qualitative research underpinning the evolving discipline of palliative care, including clinical trials of pain or symptom control therapies, epidemiology of phenomena related to life-threatening disease and end-of-life care, instrument development to enhance clinical assessment and facilitate investigation, and health services studies evaluating the outcomes of diverse therapeutic models. It also offers extensive coverage of clinical practice issues, publishing both systematic and narrative reviews, case series and case reports, and both special articles and columns that present important updates on topics as varied as the international diversity of palliative medicine, the economics of palliative care, and bioethics in end-of-life care.
    Subscriptions

  • Annals of Oncology

    • ISSN: 0923-7534
    An official Journal of the European Society for Medical Oncology and the official journal of the Japanese Society of Medical OncologyAnnals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review publications on innovative cancer treatments or translational work related to oncology and precision medicine.Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.Wi... a large international editorial board of experts who are leaders in their fields, Annals of Oncology aims at delivering the best communication on the fast moving, and continually evolving, global oncology landscape.
    Subscriptions

  • Practical Radiation Oncology

    • ISSN: 1879-8500
    An official journal of the American Society for Radiation Oncology (ASTRO)The overarching mission of Practical Radiation Oncology is to improve the quality of radiation oncology practice. PRO's purpose is to document the state of current practice, providing background for those in training and continuing education for practitioners, through discussion and illustration of new techniques, evaluation of current practices, and publication of case reports. PRO strives to provide its readers content that emphasizes knowledge "with a purpose." The content of PRO includes:Original articles focusing on patient safety, quality measurement, or quality improvement initiativesOriginal articles focusing on imaging, contouring, target delineation, simulation, treatment planning, immobilization, organ motion, and other practical issuesASTRO guidelines, position papers, and consensus statementsEssays that highlight enriching personal experiences in caring for cancer patients and their families PRO is the sister publication to the International Journal of Radiation Oncology, Biology, Physics and Advances in Radiation Oncology. Learn more about which types of papers the journals typically accept.DisclaimerThe views expressed in Practical Radiation Oncology (the "Journal") are those of the individual authors and are not necessarily those of the American Society for Radiation Oncology (ASTRO) or the Publisher. The information contained in the Journal is not medical advice and is not intended to replace the judgment of a practitioner with respect to particular patients, procedures, or practice. No responsibility is assumed by the Publisher nor by the Society for any injury and/or damage to persons or property as a result of (i) any actual or alleged libellous statements or infringement of intellectual property or privacy rights, (ii) product liability or negligence; (iii) an author's statements or other materials; or (iv) the use or operation of any ideas, instructions, procedures, products, or methods contained in the Journal. Due to rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should always be made. In any jurisdiction that does not permit such a disclaimer of liability, the liability of ASTRO and the Publisher shall be limited to the greatest extent allowed by applicable law.Publication of an advertisement in the Journal does not constitute on the part of the Publisher or the Society a guarantee or endorsement of the quality or value of the advertised products or services described therein or of any of the representations or the claims made by the advertisers with respect to such products or services.
    Subscriptions

  • Journal of Radiology Nursing

    • ISSN: 1546-0843
    Official journal of the Association for Radiologic & Imaging Nursing (ARIN)The Journal of Radiology Nursing promotes the highest quality patient care in the diagnostic and therapeutic imaging environments. The content is intended to show radiology nurses how to practice with compassion, competence, and commitment, not only to patients but also to the profession of nursing as a whole. The journal's goals mirror those of the Association for Radiologic & Imaging Nursing: to provide, promote, maintain, and continuously improve patient care through education, standards, professional growth, and collaboration with other health care providers.
    Subscriptions

  • Journal of Geriatric Oncology

    • ISSN: 1879-4068
    The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology.Editor-in-C... Supriya Mohile, University of Rochester, USA and the Editorial Board invite you to submit a manuscript to the Journal of Geriatric Oncology. The journal welcomes the submission of manuscripts in the following categories:• Original research articles • Review articles • Clinical trials • Education and training articles • Short communications • Perspectives • Meeting reports • Letters to the EditorThe Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG).Journal of Geriatric Oncology's Inclusion and Diversity Pledge This journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader?ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
    Subscriptions

  • Medical Dosimetry

    • ISSN: 0958-3947
    Official Journal of the American Association of Medical DosimetristsMedical Dosimetry, the official journal of the American Association of Medical Dosimetrists, is the key source of information on new developments for the medical dosimetrist. Practical and comprehensive in coverage, the journal features original contributions and review articles by medical dosimetrists, oncologists, physicists, and radiation therapy technologists on clinical applications and techniques of external beam, interstitial, intracavitary and intraluminal irradiation in cancer management. Articles dealing primarily with physics will be reviewed by a specially appointed team of experts in the field.
    Subscriptions

  • Leukemia Research

    • ISSN: 0145-2126
    Official journal of the Myelodysplastic Syndromes Foundation.Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, clinical evaluation, and therapy of these diseases.You are also welcome to submit to Leukemia Research's open access companion title, Leukemia Research Reports.
    Subscriptions

  • Clinical Genitourinary Cancer

    • ISSN: 1558-7673
    Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches. Priority is given to studies using authors' own institutional or original patient cohorts. Secondary analyses of public registries or databases (e.g., SEER, TCGA) are discouraged unless they generate genuinely novel clinical or mechanistic insight not already addressable with the same data.
    Subscriptions

  • Clinical Lung Cancer

    • ISSN: 1525-7304
    Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
    Subscriptions

  • Biochimica et Biophysica Acta: Molecular Basis of Disease

    • ISSN: 0925-4439
    BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiov... diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunologica... diseasesInflammatory diseasesMetabolic diseasesMitochondria... diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computation... (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descripti... or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparati... Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.
    Subscriptions

  • Current Problems in Cancer

    • ISSN: 0147-0272
    Current Problems in Cancer seeks to promote and disseminate innovative, transformative, and impactful data on patient-oriented cancer research and clinical care. Specifically, the journal's scope is focused on reporting the results of well-designed cancer studies that influence/alter practice or identify new directions in translational and clinical cancer research. These studies can include novel therapeutic approaches, new strategies for early diagnosis, cancer clinical trials, and supportive care, among others. Pre-clinical studies are discouraged. The journal's format also allows, on occasion, for a multi-faceted overview of a single topic via a curated selection of review articles, while also offering articles that present dynamic material that influences the oncology field.Original case reports featuring prevention, diagnosis and treatment of cancer, supportive care, quality of life and rehabilitation can be submitted to the journal's open access companion title, Current Problems in Cancer: Case Reports.(CPCCR). Any case reports submitted to Current Problems in Cancer (CPC) will be considered for publication in either CPC or CPCCR.
    Subscriptions

  • Lung Cancer

    • ISSN: 0169-5002
    An International Journal for Lung Cancer and other Thoracic Malignancies. An Official Journal of the European Society for Medical Oncology. The Official Journal of ETOP IBCSG Partners Foundation. The Official Journal of the British Thoracic Oncology GroupLung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.
    Subscriptions

  • Hematology/Oncology Clinics of North America

    • ISSN: 0889-8588
    Hematology/Oncology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers—bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more. Hematology/Oncology Clinics of North America is published six times each year, in February, April, June, August, October, and December.
    Subscriptions

  • Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis

    • ISSN: 1386-1964
    A section of Mutation ResearchMutation Research (MR) provides a platform for publishing all aspects of DNA mutations and epimutations, from basic evolutionary aspects to translational applications in genetic and epigenetic diagnostics and therapy. Mutations are defined as all possible alterations in DNA sequence and sequence organization, from point mutations to genome structural variation, chromosomal aberrations and aneuploidy. Epimutations are defined as alterations in the epigenome, i.e., changes in DNA methylation, histone modification and small regulatory RNAs.MR publishes articles in the following areas:Of special interest are basic mechanisms through which DNA damage and mutations impact development and differentiation, stem cell biology and cell fate in general, including various forms of cell death and cellular senescence.The study of genome instability in human molecular epidemiology and in relation to complex phenotypes, such as human disease, is considered a growing area of importance.Mechanism... of (epi)mutation induction, for example, during DNA repair, replication or recombination; novel methods of (epi)mutation detection, with a focus on ultra-high-throughpu... sequencing.Landscape of somatic mutations and epimutations in cancer and aging.Role of de novo mutations in human disease and aging; mutations in population genomics.Interaction... between mutations and epimutations.The role of epimutations in chromatin structure and function.Mitochondri... DNA mutations and their consequences in terms of human disease and aging.Novel ways to generate mutations and epimutations in cell lines and animal models.MR supports and follows the general direction proposed by all major societies in the field part of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS):Asociacion Latinoamericana de Mutagenesis, Carcinogenesis y Teratogenesis Ambiental (ALAMCTA)Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)Chin... Environmental Mutagen Society (CEMS)European Environmental Mutagenesis and Genomics Society (EEMGS)Environmental Mutagenesis and Genomics Society (EMGS)Environmental Mutagen Society of India (EMS India)Iranian Environmental Mutagen Society (IrEMS)The Japanese Environmental Mutagen Society (JEMS)Korean Environmental Mutagen Society (KEMS)Molecular and Experimental Pathology Society of Australasia (MEPSA)Pan-African Environmental Mutagen Society (PAEMS)Philippines Environmental Mutagen Society (PEMS)Thai Environmental Mutagen Society (TEMS)Other Mutation Research sections: DNA Repair Mutation Research - Genetic Toxicology and Environmental Mutagenesis (MRGTEM) Mutation Research - Reviews (MRR)
    Subscriptions

  • Mutation Research: Genetic Toxicology and Environmental Mutagenesis

    • ISSN: 1383-5718
    A section of Mutation ResearchMutation Research: Genetic Toxicology and Environmental Mutagenesis (MRGTEM) publishes papers advancing knowledge in the field of genetic toxicology. Papers are welcomed in the following areas:New developments in genotoxicity testing of chemical agents (e.g., in methodology of assay systems and interpretation of results).Alternative... to and refinement of the use of animals in genotoxicity testing.Nano-genotox... the study of genotoxicity hazards and risks related to novel man-made nanomaterials.Studie... of epigenetic changes in relation to genotoxic effects.The use of structure-activity relationships in predicting genotoxic effects.The isolation and chemical characterization of novel environmental mutagens.The measurement of genotoxic effects in human populations, when accompanied by quantitative measurements of environmental or occupational exposures.The application of novel technologies for assessing the hazard and risks associated with genotoxic substances (e.g., OMICS or other high-throughput approaches to genotoxicity testing).Telomere biology as an endpoint for examination of the effects of chemicals and other environmental exposures.Extracts and complex mixturesAny submissions that report the results of studies on extracts or complex mixtures (e.g., solvent extracts of herbal preparations; soil, air, or water samples) will receive preliminary review by an Editor. Unless such manuscripts offer significant new insight, such as the chemical identification of previously unknown mutagens or anti-mutagens, they will be returned to the authors without being sent for further review. For further clarification of this journal policy please refer to the Editorial published in Mutation Research 391 (1997) 1.MRGTEM is now accepting submissions for a new section of the journal, "Current Topics in Genotoxicity Testing," that will be dedicated to the discussion of current issues relating to design, interpretation, and strategic use of genotoxicity tests. This section is envisaged to include discussions relating to the development of new international testing guidelines, but also to wider topics in the field. The evaluation of contrasting or opposing viewpoints is welcomed as long as the presentation is in accordance with the journal’s aims, scope, and policies.MRGTEM supports and follows the general direction proposed by all major societies in the field part of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS):Asociacion Latinoamericana de Mutagenesis, Carcinogenesis y Teratogenesis Ambiental (ALAMCTA)Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)Chin... Environmental Mutagen Society (CEMS)European Environmental Mutagenesis and Genomics Society (EEMGS)Environmental Mutagenesis and Genomics Society (EMGS)Environmental Mutagen Society of India (EMS India)Iranian Environmental Mutagen Society (IrEMS)The Japanese Environmental Mutagen Society (JEMS)Korean Environmental Mutagen Society (KEMS)Molecular and Experimental Pathology Society of Australasia (MEPSA)Pan-African Environmental Mutagen Society (PAEMS)Philippines Environmental Mutagen Society (PEMS)Thai Environmental Mutagen Society (TEMS)Other Mutation Research sections: DNA Repair Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis (MR) Mutation Research - Reviews (MRR)
    Subscriptions

  • The Lancet Oncology

    • ISSN: 1470-2045
    The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The journal is lively and informative, covering international issues relevant to clinical cancer specialties worldwide. Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology.
    Subscriptions

  • Oral Oncology

    • ISSN: 1368-8375
    A Journal Related to Head & Neck OncologyOral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck.Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngolog... plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields.Basic, translational, or clinical Research or Review papers of high quality and that make a contribution to new knowledge are invited on the following aspects of neoplasms arising in the head and neck (including lip, tongue, oral cavity, oropharynx, salivary glands, sinuses, nose, nasopharynx, larynx, skull base, thyroid, and craniofacial region, and the related hard and soft tissues and lymph nodes):• Etiopathogenesis: natural history of cancer and pre-cancer; basic pathology, metastatic mechanisms; genetic changes; cellular and molecular changes; microorganisms; growth factors, adhesion and other molecules • Epidemiology; risk factors; biomarkers; protective factors; geographic factors; prevention; screening and intervention • Clinical features; orofacial effects of neoplasms at both local and distant sites; tumor staging and grading • Diagnosis; detection of cancer and pre-cancer; cellular and molecular markers for diagnosis; advances in imaging and other functional diagnostic modalities for cancer and pre-cancer • Management and Prognosis; clinical, cellular and molecular markers for prognosis; treatment options including surgical, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of surgery, medical, radiotherapy, chemotherapy, immunotherapy, biological and gene therapy advances; molecular targets and new therapeutics (new cytotonics and molecular-targeted therapies); multimodality treatment; advances in reconstruction and rehabilitation, including flaps and grafts, alloplasty, bone and connective tissue biology; multidisciplinary teamwork in cancer care and oral health care. • Quality of life issues; issues of consent; psychosocial aspects; patient and health professional information; patient involvement; psychological interventions, improving outcomes; the prevention, diagnosis and management of complications, including, pain, hemorrhage, dysfunction, deformity, osteoradionecrosis, xerostomia, and others; rehabilitation; palliative and end of life care; and support teamwork.
    Subscriptions

  • Bone

    • ISSN: 8756-3282
    BONE is an interdisciplinary forum for the rapid publication of original articles and reviews on basic, translational, and clinical aspects of bone and mineral metabolism, including rare bone diseases. The Journal also encourages submissions related to interactions of bone with other organ systems, including cartilage, tendon and other connective tissues, endocrine, muscle, fat, neural, vascular, gastrointestinal, hematopoietic, and immune systems. Particular attention is placed on the application of artificial intelligence and experimental studies to clinical practice.US National Institutes of Health (NIH) voluntary posting ("Public Access") policy.BONE and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors.Original research articles and case reports can also be submitted to BONE's Gold Open Access companion title, Bone Reports.
    Subscriptions

  • Critical Reviews in Oncology/Hematology

    • ISSN: 1040-8428
    Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world.The journal considers articles on the following themes:Basic Experimental OncologyCareer Development and Education in OncologyClinical ResearchHematologyIm... Pathology, Genomics and omics, and Liquid BiopsyPalliative SupportPediatric OncologyRadiotherapy... Ethics, and Health PolicySolid TumorsStatistics, Meta-analysis, and Clinical Trial DesignSurgeryCritica... Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy (ISLB).All review articles, invited or submitted spontaneously, are subject to peer review before final acceptance. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.
    Subscriptions

  • Seminars in Oncology

    • ISSN: 0093-7754
    Seminars in Oncology brings you current, authoritative, and practical articles on advances in the etiology, diagnosis and management of cancer. The journal is dedicated to providing both the basic knowledge needed to better understand cancer-related subjects as well as evidence-based perspectives from leaders in the field. Seminars in Oncology also seeks to be a venue for sharing diverse viewpoints, including innovative and unconventional ideas that might be considered "outside the box". We encourage a healthy, constructive and respectful exchange of opinions and welcome your insights as well as suggestions for topics worthy of coverage. By deepening readers understand of the basic biology and therapy of cancer through expert insights, and by fostering an open exchange of ideas, Seminars in Oncology aims to advance the science and practice of cancer care.
    Subscriptions

  • Clinical Breast Cancer

    • ISSN: 1526-8209
    Clinical Breast Cancer is a peer-reviewed journal dedicated to publishing original articles on all aspects of clinical and translational research related to breast cancer. The journal focuses on the latest scientific advancements in the detection, diagnosis, prevention, and treatment of breast cancer.Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.Manuscrip... reporting non-clinical or translational studies must include functional experiments that directly support the study’s conclusions. Purely correlative studies without functional validation or mechanistic insights will not be considered. All research should demonstrate a clear and direct relevance to the clinical setting, highlighting potential implications for patient care or therapeutic development.
    Subscriptions

  • Cancer Treatment Reviews

    • ISSN: 0305-7372
    Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.Journal of Cancer Treatment Reviews' Inclusion and Diversity PledgeThis journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
    Subscriptions

  • Current Advances in Cancer Research

    • ISSN: 0895-9803
    Subscriptions

  • Mutation Research: Reviews in Mutation Research

    • ISSN: 1383-5742
    The subject areas of Mutation Research - Reviews in Mutation Research (MRR) encompass the entire spectrum of the science of mutation research and its applications, with particular emphasis on the relationship between mutation and disease. Thus, this section will cover:Advances in human genome research (including evolving technologies for mutation detection and functional genomics) with applications in clinical genetics, gene therapy and health risk assessment for environmental agents of concernGenetic toxicology and environmental mutagenesis (including the factors that modulate the genetic activity of environmental agents) will continue to be prominent topics in this section.MRR supports and follows the general direction proposed by all major societies in the field part of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS):Asociacion Latinoamericana de Mutagenesis, Carcinogenesis y Teratogenesis Ambiental (ALAMCTA)Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)Chin... Environmental Mutagen Society (CEMS)European Environmental Mutagenesis and Genomics Society (EEMGS)Environmental Mutagenesis and Genomics Society (EMGS)Environmental Mutagen Society of India (EMS India)Iranian Environmental Mutagen Society (IrEMS)The Japanese Environmental Mutagen Society (JEMS)Korean Environmental Mutagen Society (KEMS)Molecular and Experimental Pathology Society of Australasia (MEPSA)Pan-African Environmental Mutagen Society (PAEMS)Philippines Environmental Mutagen Society (PEMS)Thai Environmental Mutagen Society (TEMS)Other Mutation Research sections: DNA Repair Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis (MR) Mutation Research - Genetic Toxicology and Environmental Mutagenesis (MRGTEM)
    Subscriptions

  • Cancer Letters

    • ISSN: 0304-3835
    Cancer Letters is an international journal providing a forum for original and pertinent contributions in cancer research.Cancer Letters considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine, including metronomic chemotherapy.
    Subscriptions

  • Surgical Oncology Clinics of North America

    • ISSN: 1055-3207
    Published four times each year—January, April, July, and October— Surgical Oncology Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in surgical oncology, including pancreatic cancer, radiation oncology, breast cancer, colorectal cancer, head and neck cancer, palliative care, gene therapy, sarcomas, cancer screening, treatment of colorectal cancer, biliary tract and primary liver tumors, breast cancer, imaging, and more.
    Subscriptions

  • Magnetic Resonance Imaging

    • ISSN: 0730-725X
    An International Journal of Basic Research and Clinical ApplicationsMagnetic Resonance Imaging (MRI) is the first international multidisciplinary journal encompassing physical, life, and clinical science investigations as they relate to the development and use of magnetic resonance imaging. MRI is dedicated to both basic research, technological innovation and applications, providing a single forum for communication among radiologists, physicists, chemists, biochemists, biologists, engineers, internists, pathologists, physiologists, computer scientists, and mathematicians.
    Subscriptions

  • Clinical Colorectal Cancer

    • ISSN: 1533-0028
    Clinical Colorectal Cancer is devoted to manuscripts that focus on early detection/screening, diagnosis, prevention, and treatment of colorectal cancer and other GI cancers, including pancreatic, liver, gastric/gastroesopha... biliary, and other gastrointestinal cancers. The major emphasis is on recent scientific developments and original peer-reviewed manuscripts. Specific areas of interest include original reports on clinical research and/or translational research and translational correlative science that is directly related to clinical trials, in all (multidisciplinary) therapeutic fields that relate to colorectal cancer and other GI cancers.Further areas of interest include original research on drug sensitivity and resistance to cytotoxic agents, targeted therapies, immunotherapies, and other novel therapeutic approaches; pathology, (validated) predictive markers, and prognostic indicators; chemoprevention strategies; and integration of various therapeutic and multidisciplinary approaches. A much lower priority will be given to meta-analyses, pooled analyses, and real-world analyses unless the knowledge gained from such reports is significant and can be applied to clinical practice. In addition, unsolicited reviews are not encouraged unless there has been a discussion with the editor or deputy editors as the journal wants to ensure that reviews will provide real added value and true gain of knowledge.
    Subscriptions

  • Cellular Signalling

    • ISSN: 0898-6568
    Cellular Signalling publishes original research describing fundamental and clinical findings on the mechanisms, actions and structural components of cellular signalling systems in vitro and in vivo.Cellular Signalling aims at full length research papers defining signalling systems ranging from microorganisms to cells, tissues and higher organisms.Cellular Signalling strives to offer a fair and fast peer-review process with a single round of revisions. Reviews are by invitation-only. Short Reports are not accepted.
    Subscriptions

  • Medical Image Analysis

    • ISSN: 1361-8415
    An official journal of the MICCAI SocietyMedical Image Analysis provides a forum for the dissemination of new research results in the field of medical and biological image analysis, with special emphasis on efforts related to the applications of computer vision, virtual reality and robotics to biomedical imaging problems. The journal publishes the highest quality, original papers that contribute to the basic science of processing, analysing and utilizing medical and biological images for these purposes. The journal is interested in approaches that utilize biomedical image datasets at all spatial scales, ranging from molecular/cellular imaging to tissue/organ imaging. While not limited to these alone, the typical biomedical image datasets of interest include those acquired from:Magnetic resonanceUltrasoundC... tomographyNuclear medicineX-rayOptical and Confocal MicroscopyVideo and range data imagesThe types of papers accepted include those that cover the development and implementation of algorithms and strategies based on the use of various models (geometrical, statistical, physical, functional, etc.) to solve the following types of problems, using biomedical image datasets: representation of pictorial data, visualization, feature extraction, segmentation, inter-study and inter-subject registration, longitudinal / temporal studies, image-guided surgery and intervention, texture, shape and motion measurements, spectral analysis, digital anatomical atlases, statistical shape analysis, computational anatomy (modelling normal anatomy and its variations), computational physiology (modelling organs and living systems for image analysis, simulation and training), virtual and augmented reality for therapy planning and guidance, telemedicine with medical images, telepresence in medicine, telesurgery and image-guided medical robots, etc.
    Subscriptions

  • Cytotherapy

    • ISSN: 1465-3249
    Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell, gene, and extracellular vesicle therapy.Cytotherapy considers manuscripts exploring the following topics:Development and/or characterization of novel gene therapies and cell and/or EV-based therapeuticsDesign of novel therapeutic approaches employing cell/EV/gene productsScientific mechanisms of action of cell/EV/gene therapies in relevant cell-based and pre-clinical modelsScientific mechanisms of action of toxicities attributable to cell/EV/gene therapiesIdentificat... of novel biomarkers that predict the potency of cell/EV/gene therapies and/or stratify patients based on response ratesEarly and late phase clinical studies evaluating the safety and efficacy of cell/EV/gene therapiesImportant advances in cell/EV/gene-based product manufacturing and validationGlobal/reg... regulatory practices that impact the authorized use and/or regulatory approval of cell/EV and gene therapiesCytotherapy does not publish manuscripts on the following topics:Case studies unless they are of unusual significance to the fieldBasic/translati... studies exploring the role of lncRNAs, circRNAs, and miRNAs in disease pathophysiologyFunda... scientific studies of normal or pathological processesStudies describing signaling pathways implicated in cancer
    Subscriptions

  • Seminars in Radiation Oncology

    • ISSN: 1053-4296
    Each issue of Seminars in Radiation Oncology is compiled by a guest editor to address a specific topic in the specialty, presenting definitive information on areas of rapid change and development. A significant number of articles report new scientific information. Topics covered include tumor biology, diagnosis, medical and surgical management of the patient, and new technologies.
    Subscriptions